ATE328598T1 - Stabile oxazaphosphorin-2-mercaptoethansulphonat formulierungen - Google Patents

Stabile oxazaphosphorin-2-mercaptoethansulphonat formulierungen

Info

Publication number
ATE328598T1
ATE328598T1 AT03255566T AT03255566T ATE328598T1 AT E328598 T1 ATE328598 T1 AT E328598T1 AT 03255566 T AT03255566 T AT 03255566T AT 03255566 T AT03255566 T AT 03255566T AT E328598 T1 ATE328598 T1 AT E328598T1
Authority
AT
Austria
Prior art keywords
mercaptoethanesulphonate
oxazaphosphorine
cyclodextrin
formulations
beta
Prior art date
Application number
AT03255566T
Other languages
English (en)
Inventor
Gautam Vinod Daftary
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Kumar Subbappa Praveen
Original Assignee
Bharat Serums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd
Application granted granted Critical
Publication of ATE328598T1 publication Critical patent/ATE328598T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
AT03255566T 2002-09-05 2003-09-05 Stabile oxazaphosphorin-2-mercaptoethansulphonat formulierungen ATE328598T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN809MU2002 2002-09-05

Publications (1)

Publication Number Publication Date
ATE328598T1 true ATE328598T1 (de) 2006-06-15

Family

ID=31503923

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03255566T ATE328598T1 (de) 2002-09-05 2003-09-05 Stabile oxazaphosphorin-2-mercaptoethansulphonat formulierungen

Country Status (16)

Country Link
US (1) US20050272698A1 (de)
EP (1) EP1396268B1 (de)
JP (1) JP2006508917A (de)
KR (1) KR101037313B1 (de)
CN (1) CN1694713A (de)
AT (1) ATE328598T1 (de)
AU (1) AU2003276689B2 (de)
BR (1) BR0314068A (de)
CA (1) CA2497898C (de)
DE (1) DE60305813T2 (de)
EA (1) EA008776B1 (de)
ES (1) ES2266734T3 (de)
MX (1) MXPA05002453A (de)
NZ (1) NZ538584A (de)
WO (1) WO2004022699A2 (de)
ZA (1) ZA200501869B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4611029B2 (ja) * 2002-12-02 2011-01-12 ブハラット セルムズ アンド ヴァクシンズ リミテッド 非経口投与用のイホスファミド組成物及びその製造方法
DE10346134A1 (de) * 2003-10-01 2005-04-21 Baxter Healthcare Sa Neue Verwendung, pharmazeutische Zubereitungen sowie Verfahren zu deren Herstellung
US8093230B2 (en) * 2003-10-01 2012-01-10 Baxter International Inc. Supersaturated aqueous ifosfamide compositions
JP2008512447A (ja) * 2004-09-13 2008-04-24 ブハラット セルムズ アンド ヴァクシンズ リミテッド 防腐作用を有する静脈投与用の安定な乳剤組成物
EP1957082B1 (de) * 2005-12-02 2012-04-11 The Johns Hopkins University Verwendung von hochdosierten oxazaphosphorin-arzneimitteln zur behandlung von immunstörungen
WO2008034071A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Method of identifying patients suitable for high-dose cyclophosphamide treatment
WO2008034076A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Cyclophosphamide in combination with immune therapeutics
WO2008034074A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Cyclosphosphamide in combination with anti-idiotypic vaccines
WO2009067699A2 (en) * 2007-11-21 2009-05-28 Accentia Biopharmaceuticals, Inc. Methods for providing a system of care for an oxazaphosphorine drug regimen
US9026372B2 (en) * 2007-11-21 2015-05-05 Accentia Biopharmaceuticals, Inc. Methods for providing a system of care for a high-dose oxazaphosphorine drug regimen
US10849916B2 (en) 2014-07-11 2020-12-01 Dr. Reddys Laboratories Limited Stable liquid formulations of cyclophosphamide and its impurities
WO2016005962A2 (en) 2014-07-11 2016-01-14 Dr. Reddy’S Laboratories Limited Stable liquid formulations of cyclophosphamide and processes

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220660A (en) * 1977-12-14 1980-09-02 Asta-werke Aktiengesellschaft, Chemische Farik Process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US6407079B1 (en) * 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
DE3772482D1 (de) * 1986-07-11 1991-10-02 Asta Pharma Ag Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung.
NO873860L (no) * 1986-10-31 1988-05-02 Asta Pharma Ag Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling.
US4879286A (en) * 1987-01-28 1989-11-07 Lyphomed, Inc. Cyclophosphamide
ATE65402T1 (de) * 1988-03-19 1991-08-15 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
IE62095B1 (en) * 1988-03-29 1994-12-14 Univ Florida Pharmaceutical formulations for parenteral use
WO1991004026A1 (en) * 1989-09-14 1991-04-04 Australian Commercial Research & Development Limited Drug delivery compositions
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
US5602112A (en) * 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
SI9300470A (en) * 1993-09-10 1995-04-30 Lek Tovarna Farmacevtskih Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
US5919816A (en) * 1994-11-14 1999-07-06 Bionumerik Pharmaceuticals, Inc. Formulations and methods of reducing toxicity of antineoplastic agents
PL178713B1 (pl) * 1995-03-31 2000-06-30 Centrum Badan Molekularnych I Makromolekularnych Pan Środek farmaceutyczny o działaniu przeciwnowotworowym
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
ITMI20011338A1 (it) * 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo

Also Published As

Publication number Publication date
ES2266734T3 (es) 2007-03-01
KR101037313B1 (ko) 2011-05-26
EA008776B1 (ru) 2007-08-31
DE60305813T2 (de) 2007-06-28
EA200500315A1 (ru) 2005-08-25
EP1396268B1 (de) 2006-06-07
EP1396268A1 (de) 2004-03-10
DE60305813D1 (de) 2006-07-20
KR20050057229A (ko) 2005-06-16
AU2003276689A1 (en) 2004-03-29
MXPA05002453A (es) 2005-05-27
ZA200501869B (en) 2007-11-28
BR0314068A (pt) 2005-07-05
AU2003276689B2 (en) 2009-04-09
JP2006508917A (ja) 2006-03-16
WO2004022699A3 (en) 2005-03-24
NZ538584A (en) 2007-05-31
CN1694713A (zh) 2005-11-09
WO2004022699A2 (en) 2004-03-18
CA2497898A1 (en) 2004-03-18
CA2497898C (en) 2012-02-07
US20050272698A1 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
ZA200501869B (en) Liquid stable composition of oxazaphosphorine with mesna
TR200002366T2 (tr) Herbisit aktif 3-hidroksi-4-aril-5-oksopirazolin türevleri.
AR030413A1 (es) Antranilamidas insecticidas
BR0116345A (pt) Composiçõs de contra-ação ao mau cheiro
FR11C0038I2 (fr) Analogues macrocycliques, leurs procedes d'utilisation et de preparation
CR9602A (es) Nuevos derivados de 2,4-dianilinpirimidinas, su preparacion, como medicamentos, composiciones farmaceuticas y particularmente como inhibidores de ikk
DK1401837T3 (da) Purinderivater som A2B-adenosinreceptorantagonister
MY141869A (en) Mouth rinse compositions
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
TW200613279A (en) New pesticides
DE60228990D1 (de) Bicyclische verbindung
ES2040366T3 (es) Procedimiento de preparacion de nuevos derivados de 1-(bencilpiperidino)2-propanol.
DE60031886D1 (de) Purinderivate
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
DE69940551D1 (de) Mercaptane und disulfide
ES2183709B1 (es) Composicion para el control de artropodos.
ES2179857T3 (es) Derivados de quinoleina sustituidos, procedimiento para su preparacion y su utilizacion.
AP2004003168A0 (en) Phosphonates and derivatives thereof as enhancers of the activity of insecticides
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
MX2007003174A (es) Sales de disulfuro medicinales.
BR0316996B1 (pt) Derivados de 1-aril-3-amidoxima-pirazol pesticida
AR019701A1 (es) Compuestos derivados de alfa-d-xilosa, preparacion y su utilizacion en terapeutica
ATE451122T1 (de) Stabile wässrige formulierungen eines platin derivats
TR200300551T2 (tr) Agrokimyasal kompozisyon
UY28983A1 (es) Agentes plaguicidas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties